amphetamine has been researched along with Affective Disorders, Psychotic in 2 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Affective Disorders, Psychotic: Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines whether illicit amphetamine use is associated with differences in the prevalence of specific psychiatric symptoms in a community sample of individuals diagnosed with schizophrenia or affective psychotic disorders." | 7.88 | The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses. ( Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A, 2018) |
| "This study examines whether illicit amphetamine use is associated with differences in the prevalence of specific psychiatric symptoms in a community sample of individuals diagnosed with schizophrenia or affective psychotic disorders." | 3.88 | The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses. ( Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voce, A | 1 |
| McKetin, R | 1 |
| Burns, R | 1 |
| Castle, D | 1 |
| Calabria, B | 1 |
| Post, RM | 1 |
| Uhde, TW | 1 |
| Putnam, FW | 1 |
| Ballenger, JC | 1 |
| Berrettini, WH | 1 |
1 review available for amphetamine and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Kindling and carbamazepine in affective illness.
Topics: Affective Disorders, Psychotic; Amphetamine; Amygdala; Animals; Bipolar Disorder; Carbamazepine; Coc | 1982 |
1 other study available for amphetamine and Affective Disorders, Psychotic
| Article | Year |
|---|---|
The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Amphetamine; Amphetamine-Related Disorders; Austr | 2018 |